We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
- Authors
Alvarez, Enrique; Piccio, Laura; Mikesell, Robert J; Klawiter, Eric C; Parks, Becky J; Naismith, Robert T; Cross, Anne H
- Abstract
CXCL13, a B-cell chemokine, has been proposed as a biomarker in a variety of conditions, some of which can mimic multiple sclerosis and can have very high levels. In this case-control study, cerebrospinal fluid (CSF) CXCL13 was elevated in multiple sclerosis, neuromyelitis optica and other inflammatory neurological controls compared with noninflammatory controls. Levels did not differentiate disease groups. For all subjects taken together, CSF CXCL13 correlated with CSF WBC, oligoclonal band numbers, CSF protein, EDSS, and neurofilament levels. In subgroup analyses, CSF CXCL13 correlated with CSF WBC in neuromyelitis optica and IgG index in multiple sclerosis. Additionally, serum CXCL13 was elevated in neuromyelitis optica.
- Subjects
BIOMARKERS; MULTIPLE sclerosis; CEREBROSPINAL fluid; CHEMOKINES; B cells
- Publication
Multiple Sclerosis Journal, 2013, Vol 19, Issue 9, p1204
- ISSN
1352-4585
- Publication type
Article
- DOI
10.1177/1352458512473362